SuperworthXometry XMTR
- Market cap
- $5.1B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 6.3×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $807.5M
- +34% on a year ago
- Net margin
- −3.8%
- Free cash flow yield
- n/m
- not a meaningful number
Xometry trades at 6.3× sales. Its trailing earnings are negative, so it has no PE. Revenue was $807.5M over the last twelve months, up 34% on a year earlier with a −4% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $118.9M+15% | $128.1M+31% | $122.7M+17% | $132.6M+19% | $141.7M+19% | $148.5M+16% | $151M+23% | $162.5M+23% | $180.7M+28% | $192.4M+30% | $205.1M+36% | $229.3M+41% | |
| Cost of revenue | $72.7M+16% | $79.1M+24% | $74.8M+13% | $79.7M+18% | $85.9M+18% | $89.5M+13% | $94.6M+27% | $97.4M+22% | $108.7M+27% | $117.2M+31% | $126.7M+34% | $142.1M+46% |
| Gross profit | $46.2M+13% | $49.1M+43% | $47.9M+22% | $52.9M+21% | $55.8M+21% | $59M+20% | $56.3M+18% | $65.2M+23% | $72M+29% | $75.2M+28% | $78.5M+39% | $87.2M+34% |
| R&D | $8.5M+12% | $8.9M+7% | $9.6M+18% | $10M+12% | $9.3M+10% | $10.4M+17% | $11.2M+17% | $11M+10% | $12.5M+34% | $12.1M+17% | $11.4M+2% | $13M+18% |
| SG&A | $38.1M+4% | $39.8M−2% | $42.1M+10% | $44M−9% | $43.3M+13% | $44M+11% | $43.5M+3% | $46.7M+6% | $52.1M+21% | $52.7M+20% | $52.6M+21% | $58.3M+25% |
| −$13.2M−13% | −$12.5M−48% | −$17.9M−10% | −$15.3M−46% | −$11.5M−13% | −$11.5M−8% | −$15.4M−14% | −$10.3M−33% | −$11.1M−4% | −$8.8M−24% | −$5.2M−66% | −$5.5M−46% | |
| Interest expense | $1.2M+1% | $1.2M−5% | $1.2M−1% | $1.2M−0% | $1.2M−2% | $1.2M+0% | $1.2M−0% | $1.2M−1% | $1.3M+8% | $1.3M+6% | $1.3M+6% | $1.3M+6% |
| Pre-tax income | −$11.9M−21% | −$11.1M−53% | −$16.6M−9% | −$13.7M−49% | −$10.2M−14% | −$9.9M−11% | −$15.1M−9% | −$26.4M+93% | −$11.6M+14% | −$8M−19% | −$5M−67% | −$5M−81% |
| $139K | −$561K | $0 | −$10K−85% | $30K−78% | −$41K−93% | $0 | −$8K−20% | −$17K | $614K | $248K | $354K | |
| Net income | −$12M−20% | −$10.6M−57% | −$16.6M−9% | −$13.7M−48% | −$10.2M−15% | −$9.9M−6% | −$15.1M−9% | −$26.4M+93% | −$11.6M+14% | −$8.6M−13% | −$5.3M−65% | −$5.3M−80% |
| −$0.25−22% | −$0.22−57% | −$0.34−11% | −$0.28−49% | −$0.21−16% | −$0.20−9% | −$0.30−12% | −$0.52+86% | −$0.23+10% | −$0.17−15% | −$0.10−67% | −$0.10−81% | |
| 48M+2% | 48.1M+1% | 48.6M+2% | 48.8M+2% | 49.3M+3% | 49.6M+3% | 50.3M+4% | 50.7M+4% | 50.9M+3% | 51.3M+3% | 51.9M+3% | 54.2M+7% |
Revenue: Q1 FY20: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY20: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
R&D: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
SG&A: Q1 FY20: 6 months less the 3 months printed beside them.
Operating income: Q1 FY20: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY20: 6 months less the 3 months printed beside them.
Net income: Q1 FY20 and Q1 FY21: 6 months less the 3 months printed beside them.
EPS, diluted: 8 periods, Q1 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY20: share-days: the 6-month average less the second quarter's. 6 periods, Q4 FY20 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial - Credit Services nearest Xometry's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| XMTRXometry | $5.1B | n/m | n/a | 6.3× | +34% | −3.8% | |
| FIGRFigure Technology Solutions | $5.2B | 24.2× | 33.2× | 7.3× | +89% | 33.5% | |
| RELYRemitly Global | $5.3B | 17.9× | 55.1× | 2.9× | +24% | 16.9% | |
| AMTMAmentum | $5.3B | 26.2× | 60.6× | 0.4× | +11% | 1.4% | |
| CACCCredit Acceptance | $5.7B | 12.0× | 14.0× | 2.4× | +3% | 21.5% | |
| DAVEDave | $4.5B | 23.0× | 22.7× | 7.0× | +49% | 34.6% | |
| SEZLSezzle | $4.4B | 29.0× | 27.8× | 8.4× | +43% | 30.4% | |
| NNINelnet | $4.4B | 14.7× | 11.2× | 3.7× | +6% | 25.8% | |
| PAYPaymentus | $4.2B | 50.5× | 97.8× | 3.1× | +30% | 6.2% | |
| OMFOneMain | $6.4B | 8.4× | 9.1× | 1.3× | +8% | 15.4% | |
| EXLSExlService | $6.4B | 26.6× | 34.7× | 2.9× | +14% | 11.2% | |
| Peer median | $5.2B | 23.6× | 30.5× | 3.0× | +19% | 19.2% |
Investors who own it
Investors we follow who held Xometry at the end of Jun 30, 2026, from their 13F filings.
- Henry EllenbogenDurable Capital Partners1.0% of portfolioadded
- Baillie GiffordBaillie Gifford0.1% of portfoliotrimmed
- Cathie WoodARK Investment Management0.0% of portfolioadded
More on Xometry
Each number over time
- PE ratio
- Price to sales ratio
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Financial - Credit Services
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .